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Human blood group A- and H-antigenic glycosphingolipids were isolated from pooled porcine plasma. The structures of the A-active hexa- and 
H-active pentaglycosylceramides of lactoseries (type 1 sugar chain) were the same as those in porcine erythrocytes. These results endorse biochemi- 
cally the previous observations that the A and H antigens on porcine erythrocytes are taken up from plasma. 
AH blood groups; Glycolipid; Lactoscries; (Pig plasma) 
1. INTRODUCTION 
One of the important roles of plasma glycolipids is to 
act as blood group antigens through transferring an- 
tigenic glycolipids from plasma to erythrocytes, as was 
demonstrated in the Lewis system [1,2]. Similarly to 
Lewis antigens in man, some of porcine blood group 
antigens including human type-A and -H on 
erythrocytes are acquired from plasma [3], although 
the antigens have not been chemically characterized. In 
a previous study, we identified human blood group A- 
and ~-antigenic glycolipids belonging to lactoseries in 
porcine erythrocyte membranes [4]. Therefore, if the 
antigenic glycolipids present in porcine erythrocytes are 
found in the plasma as well, this will endorse acquisi- 
tion of the erythrocyte antigens from plasma. The pre- 
sent study deals with isolation and characterization of 
the antigenic glycolipids in porcine plasma. 
2. EXPERIMENTAL 
The ratio of a solvent mixture is expressed by volume. Fresh, 
pooled, titrated, porcine blood was centrifuged. The supernatant 
plasma was saturated with ethanol to a final concentration of 70% 
followed by ~ltration. The residue was extracted with 70% ethanol 
at 70°C for a few minutes. First and second filtrates were combined, 
and evaporated to dryness. The dried materials were subjected to 
removal of phospholipids [5], and extracted 3 times with CHCW 
CH3OH (2: 1). From the combined extracts, neutral glycolipids were 
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separated by repeated silicic acid chromatographies as described 
previously [4,6]. All analytical methods including proton nuclear 
magnetic resonance (PMR) spectrometry, glycosidase treatment, 
hemagglutination inhibition test and solid phase immunostaining 
were the same as those described previously [4]. 
3. RESULTS 
Major glycolipids isolated from porcine plasma were 
mono- to tetraglycosylceramides with predominant 
GbKer as was demonstrated previously [7,8]. In addi- 
tion, two minor glycolipids having longer carbohydrate 
chains, which co~grated with blood group A and H 
glycolipids from porcine er~hroc~es [4], were purified 
at about 2.9 mg and 1.6 mg per 10 liters, respec- 
tively. When two glycolipids were examined for human 
blood group antigenicity by hemagglutination inhibi- 
tion, the respective lipids exhibited the A activity at 
0.15 ng/,ul and H activity at 38 ng//rl. Results of the 
immunostaining are shown in fig.1. No type B 
glycolipid was detected in porcine plasma. Upon treat- 
ment of the plasma A glycolipid with a-ZV-acetyl- 
galactosaminidase, cu-L-fucosidase, &galactosidase 
and then ~-~-acetylhexosami~dase followed by thin- 
layer chromatography developed with CHCLI 
CH30H/H20 (60: 35 : 8; solvent l), the lipid was con- 
verted to glycolipids migrating as penta-, tetra-, tri- and 
diglycosylceramides, respectively (data not shown). 
The A and H glycolipids were analyzed by PMR spec- 
trometry referring to previous spectra for signal assign- 
ment and molar composition [9-l 11. The spectra of the 
A (fig.2a) and H (fig.2b) glycolipids were identical with 
respective ones from the porcine erythrocytes [4]. Pro- 
tons at H-l (4.616 ppm) and H-3 (3.849 ppm) of 
GlcNAc, which are characteristic of lacto-core 
skeleton, were observed in both glycolipids. 
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The above results are consistent with the chemical 
structures of GalNAccvl-3(Fu~l-2)Gal,&3GlcNAc#l- 
3Galpl-4Glc#l-1Cer for the A glycolipid, and with that 
lacking GalNAc from the A glycolipid for the H 
glycolipid. 
Fig. 1. Solid phase immunostaining of A- and H-antigenic glycolipids 
from porcine plasma. The A glycolipid (lanes l-3), the H glycolipid 
(lanes 5 and 6) and standards (LacCer, GbsCer and Gb&er at lane 
4) were chromatographed on thin-layer plates developed with solvent 
1. Lanes 1, 4 and 5 were visualized with an orcinol-HzS04 reagent. 
Lanes 2 and 3 were treated with anti-A antiserum and Doiichos 
biflorus lectin (followed by anti-D. biforus IgG), respectively. Lane 
6 was treated with Uiex europoeus II lectin and with anti-U. 
europam II IgG. Then, the lipids on lanes 2,3 and 6 were visualized 
with 4-chlor~l-naphthoi solution containing Hz02 after treatment 
with protein A-conjugated peroxidase. 
4. lXSCUSSION 
Porcine blood group antigenicity is grouped into 
more than 10 systems, each of which is classified into 
plural subtypes based on serological reactivity [3]. They 
include the antigenicities imilar to human type-A and 
-H. In pigs with human type-A or -H blood group, the 
antigenicity is detected in digestive secretions 1121 and 
serum [13] but not on red blood cells at birth. The A 
and H antigenicity on the red cells can be detected dur- 
ing the first month of life. Acquisition of the A an- 
tigenicity onto porcine red cells from plasma was 
demonstrated [3], and the A antigenicity was detected 
in a lipid fraction from porcine serum [14]. Therefore, 
our present and previous [4] results strongly support 
that the porcine A and H glycolipids on erythrocyte are 
transferred from plasma, endorsing biochemically the 
previous serological observations. Although lactoseries 
glycolipids including ABH antigens have been 
b L4 a-Fuc 
$-Gal 
Fig.2. PMR spectra of the porcine antigenic glycolipids. The spectra of the A (a) and H (b) glycolipids were taken in hexadeutero- 
dimethyls~foxide ~ont~ning 2% l&O at 90°C in a Varian JNM~X5~ spectrometer (frequency, SO0 MHz; sweep width, 5 kHz). L and F, 
protons at long chain base and fatty acids, respectively. Peaks marked by asterisks in (a) are due to hydroxy protons [4]. 
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characterized in such glandular tissues as 
gastrointestines but few in other tissues (reviewed in 
[l&16]), minor A glycolipids with lacto-core were 
recently demonstrated in human Leamb- erythrocytes 
[ 171 and plasma [18]. Thus, it is likely that ABH and 
Lewis blood group glycolipids belonging to lactoseries 
in man and pig originate from glandular tissues. 
PI 
PI 
PO1 
1111 
1121 
REFERENCES 1131 
VI 
PI 
I31 
[41 
/71 
Marcus, D.M. and Cass, L.E. (1969) Science 164, 553-555. 
Hanfland, P. (1978) Eur. J. Biochem. 87, 161-170. 
Andresen, E. (1962) Ann. NY Acad. Sci. 97, 205-220. 
Sako, F., Gasa, S., Makita, A., Hayashi, A. and Nozawa, S. 
(1989) Arch. B&hem. Biophys. in press. 
Gasa, S. and Makita, A. (1980) J. Biochem. 88, 1119-1128. 
Sako, F., Casa, S. and Makita, A. (1987) Int. J. Biochem. 19, 
923-929. 
Dawson, G. and Sweeley, C.C. (1970) J. Biol. Chem. 245, 
410-416. 
[I41 
Il.51 
If61 
I171 
[IsI 
Clarke, J.T.R. and Stoltz, J.M. (1979) Can. J. B&hem. 57, 
1229-1236. 
Dabrowski, J., Hanfland, P. and Eg8e, H. (1980) Biochemistry 
22, 5652-5658. 
Dabrowski, J., Hanfland, P., Egge, H. and Dabrowski, U. 
(1981) Arch. Biochem. Biophys. 210, 405-411. 
Gasa, S., Mitsuyama, T. and Makita, A. (1983) J. Lipid Res. 
24, 174-182. 
Goodwin, R.F.W. and Coombs, R.R.A. (1956) J. Comp. 
Pathol. 66, 317-331. 
Saison, R. and Ingram, D.G. (1962) Ann. NY Acad. Sci. 97, 
226-232. 
Thiele, O.W. and Koch, J. (1973) VOX Sang. 25, 317-326. 
Hakomori. S. and Young, W.W. jr (1983) Handbook of Lipid 
Res. 3, 381-436. 
Makita, A. and Taniguchi, N. (1985) New Compr. Biochem. 
10, l-99. 
Clausen, H., Levery, S.B., McKibbin, J.M. and Hakomori, S. 
(1985) Biochemistry 24, 3578-3586. 
Jovail, P.-A., Lindstrom, K., Pascher, L, Pimlott, W. and 
Samuelsson, B.E. (1985) Arch. Biochem. Biophys. 257, 
409-415. 
314 
